Search
Grace Therapeutics, Inc
GRCEAdd to Watchlist
2.170USD
+0.010+0.46%
Market hours （ET）Quotes delayed by 15 min
35.31MMarket Cap
LossP/E TTM
Grace Therapeutics, Inc's Company Valuation
Currency: USD Updated: 2026-08-14The current valuation score of Grace Therapeutics, Inc is 7.07, ranking 285 out of 387 in the Biotechnology & Medical Research industry. Its current P/E ratio is -6.93, which is -95.85% below the recent high of -0.29 and -137.50% above the recent low of -16.47.
P/E
Relevant data have not been disclosed by the company yet.
P/B
Relevant data have not been disclosed by the company yet.
P/CF
Relevant data have not been disclosed by the company yet.